Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 45 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

45 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Feb. 28, 2018 DBD P 3,000 $16.05 $48,150 71,829 Direct +4.36% Acquired 297.3% (price as of 2026-10-02)
July 21, 2017 DBD P 2,000 $21.53 $43,060 49,484 Direct +4.21% Acquired 196.2% (price as of 2026-10-02)
Feb. 15, 2012 DBD S 7,876 $38.35 $302,045 12,524 Direct -38.61% Disposed 66.3% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Feb. 1, 2018 DBD Non-Qualified Stock Option [F1,F2] Common Shares (39,572) $18.75 Feb. 1, 2028 39,572 Acquired
Feb. 1, 2018 DBD Non-Qualified Stock Option [F6] Common Shares (58,064) $18.75 Feb. 1, 2028 58,064 Acquired
Feb. 8, 2017 DBD Non-Qualified Stock Options [F5] Common Shares (75,658) $26.60 Feb. 7, 2027 75,658 Acquired
Feb. 3, 2016 DBD Non-Qualified Stock Option [F5] Common Shares (55,866) $27.39 Feb. 3, 2026 55,866 Acquired
Feb. 5, 2015 DBD Non-Qualified Stock Option [F5] Common Shares (37,445) $32.33 Feb. 5, 2025 37,445 Acquired
Feb. 12, 2014 DBD Non-Qualified Stock Option [F5] Common Stock (10,166) $34.13 Feb. 15, 2024 10,166 Acquired
Feb. 6, 2013 DBD Non-qualified Stock Option [F4] Common Stock (7,540) $29.87 Feb. 5, 2023 7,540 Acquired
Feb. 25, 2012 DBD Non-qualified Stock Option Common Stock (2,500) $27.88 Feb. 10, 2020 2,500 Disposed
Feb. 15, 2012 DBD Non-qualified Stock Option Common Stock (2,500) $25.53 Feb. 12, 2018 2,500 Disposed
Feb. 15, 2012 DBD Non-qualified Stock Option Common Stock (3,750) $24.79 Feb. 10, 2019 3,750 Disposed
Feb. 8, 2012 DBD Non-qualified Stock Option [F4] Common Stock (9,500) $34.89 Feb. 7, 2022 9,500 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 15 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Jan. 18, 2012 DBD Common Stock 252 Indirect
Jan. 18, 2012 DBD Common Stock 2,350 Direct
Jan. 18, 2012 DBD Non-qualified Stock Option→ Common Stock (700) 700 Direct
Jan. 18, 2012 DBD Non-qualified Stock Option→ Common Stock (1,250) 1,250 Direct
Jan. 18, 2012 DBD Non-qualified Stock Option→ Common Stock (2,500) 2,500 Direct
Jan. 18, 2012 DBD Non-qualified Stock Option→ Common Stock (5,000) 5,000 Direct
Jan. 18, 2012 DBD Non-qualified Stock Option→ Common Stock (5,000) 5,000 Direct
Jan. 18, 2012 DBD Non-qualified Stock Option→ Common Stock (7,000) 7,000 Direct
May 9, 2011 DBD Common Stock 8,000 Direct
May 9, 2011 DBD Non-qualified Stock Option→ Common Stock (700) 700 Direct
May 9, 2011 DBD Non-qualified Stock Option→ Common Stock (1,250) 1,250 Direct
May 9, 2011 DBD Non-qualified Stock Option→ Common Stock (2,500) 2,500 Direct
May 9, 2011 DBD Non-qualified Stock Option→ Common Stock (5,000) 5,000 Direct
May 9, 2011 DBD Non-qualified Stock Option→ Common Stock (5,000) 5,000 Direct
May 9, 2011 DBD Non-qualified Stock Option→ Common Stock (7,000) 7,000 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

DBD

CFO
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2016 · · · · $331,500 $47,575 $39,797 $1,919,629
2013 $239,238 · · · $184,100 · $20,366 $691,450

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.